Evidence map›Paper›PMID 30201799›Full record

ArticleEMBO reports2018

Acetylation of SUMO2 at lysine 11 favors the formation of non-canonical SUMO chains.

Anne Gärtner, Kristina Wagner, Soraya Hölper, Kathrin Kunz, Manuel S Rodriguez, Stefan Müller

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. The physical and evolutionary energy landscapes of devolved protein sequences corresponding to pseudogenes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. SUMO Chains Rule on Chromatin Occupancy.Frontiers in cell and developmental biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anne GärtnerInstitute of Biochemistry II, Medical School, Goethe University, Frankfurt, Germany.
Kristina WagnerInstitute of Biochemistry II, Medical School, Goethe University, Frankfurt, Germany.
Soraya HölperInstitute of Biochemistry II, Medical School, Goethe University, Frankfurt, Germany.
Kathrin KunzInstitute of Biochemistry II, Medical School, Goethe University, Frankfurt, Germany.
Manuel S RodriguezInstitut des Technologies Avancées en sciences du Vivant-UPS and IPBS-CNRS, Toulouse Cedex 1, France.
Stefan MüllerInstitute of Biochemistry II, Medical School, Goethe University, Frankfurt, Germany ste.mueller@em.uni-frankfurt.de.ORCID 0000-0002-8792-7700
Goethe University Frankfurt · DECentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-translational modifications by ubiquitin-related SUMO modifiers regulate cellular signaling networks and protein homeostasis. While SUMO1 is mainly conjugated to proteins as a monomer, SUMO2/3 can form polymeric chains. Poly-SUMOylation is best understood in the SUMO-targeted ubiquitin ligase (StUbL) pathway, where chains prime proteins for subsequent ubiquitylation by StUbLs. SUMO chains typically form in response to genotoxic or proteotoxic stress and are preferentially linked via lysine 11 of SUMO2/3. Here, we report that K11 of SUMO2/3 undergoes reversible acetylation with SIRT1 being the K11 deacetylase. In a purified

Indexed as

AcetylationHeat-Shock ResponseHeLa CellsHumansLysinePromyelocytic Leukemia ProteinSignal TransductionSirtuin 1Small Ubiquitin-Related Modifier ProteinsUbiquitinsLysinePML protein, humanPromyelocytic Leukemia ProteinSIRT1 protein, humanSirtuin 1Small Ubiquitin-Related Modifier ProteinsSUMO2 protein, humanSUMO3 protein, humanUbiquitinsacetylationSIRT1SUMO chainsSUMO‐targeted ubiquitin ligase

Identifiers

PMID30201799
PMCPMC6216285
OpenAlexW2890264162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.